Terrell Owens calls Hall of Fame process ‘broken’ after Belichick, Kraft snubs

Terrell Owens calls Hall of Fame process ‘broken’ after Belichick, Kraft snubs


Terrell Owens on Hall of Fame snub and biggest financial mistakes

NFL Hall of Famer Terrell Owens said Wednesday that the recent snubs of New England Patriots owner Robert Kraft and former coach Bill Belichick from the institution show the system is flawed, and someone needs to be held accountable.

“It’s just plain dumb” Owens told CNBC Sport in an interview in San Francisco ahead of Super Bowl LX. “Something has to change.”

The decisions not to vote Kraft and Belichick into the Pro Football Hall of Fame raised eyebrows because of the Patriots’ success. With a win over the Seattle Seahawks on Sunday, the franchise would hold the most Super Bowl wins of any NFL team with seven. Belichick was the team’s head coach for all six of its championship victories, including one over Owens’ Philadelphia Eagles.

2018 Hall of Fame inductee Terrell Owens speaks during a ceremony at halftime of the game between the San Francisco 49ers and the Oakland Raiders at Levi’s Stadium on Nov. 1, 2018 in Santa Clara, California.

Daniel Shirey | Getty Images

Owens suggested it may be Jim Porter, the Hall of Fame’s president, who has the power to change the system.

“He has to change or make some some adjustments or amendments into either the criteria or the mission statement of the Hall of Fame. Something has to be done,” Owens said.

He also placed the blame on the writers responsible for voting.

“Whoever put the guidelines and the bylaws in place to ultimately land coaches and athletes in the most prestigious place that you could ever be, and that’s Canton. If the people that you’re appointed aren’t adhering to that, then something’s wrong. They should be held accountable. They should be stripped of their position,” he said.

The Pro Football Hall of Fame did not immediately respond to a request for comment.

The former six-time Pro Bowler Owens would know something about Hall of Fame voting. Owens played 15 seasons in the NFL and was inducted into the Pro Football Hall of Fame in 2018 after being passed over twice despite being ranked near the top of nearly every receiving category. Owens said it cost him financially.

“There’s a lot of complicated financial opportunity that comes with being really a first-ballot Hall of Famer. There’s a ring to it,” he added. “It used to mean so much, and now it seems to be a little bit watered down.”

When he was inducted into the Hall of Fame, Owens opted to skip the celebration in Canton, Ohio, instead holding his own celebration at the University of Tennessee at Chattanooga, his alma mater, in protest of what he called a “flawed process,” according to ESPN.

Get the CNBC Sport newsletter directly to your inbox

The CNBC Sport newsletter with Alex Sherman brings you the biggest news and exclusive interviews from the worlds of sports business and media, delivered weekly to your inbox.

Subscribe here to get access today.



Source

Real estate could be the big winner in the private credit exodus
Business

Real estate could be the big winner in the private credit exodus

A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large public companies. Sign up to receive future editions, straight to your inbox. Barely […]

Read More
Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial
Business

Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial

Eli Lilly on Thursday said its next-generation obesity drug retatrutide cleared its first late-stage trial on Type 2 diabetes patients, helping them manage their blood sugar levels and lose weight.  The drug lowered hemoglobin A1c — a key measure of blood sugar levels — by an average of 1.7% to 2% across different doses at […]

Read More
FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi
Business

FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi

Signage outside Johnson & Johnson offices in Irvine, California, US, on Friday, Oct. 10, 2025. Kyle Grillot | Bloomberg | Getty Images Johnson & Johnson on Wednesday said the U.S. Food and Drug Administration approved its once-daily psoriasis pill, the first oral option to rival best-selling shots. The FDA approved the pill, Icotyde, to treat […]

Read More